BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26445805)

  • 1. In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis.
    Mateo J; Bilbao I; Vaquero JJ; Ruiz-Cabello J; España S
    Methods Mol Biol; 2015; 1339():377-86. PubMed ID: 26445805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT Imaging of Carotid Atherosclerosis.
    Ali A; Tawakol A
    Neuroimaging Clin N Am; 2016 Feb; 26(1):45-54. PubMed ID: 26610659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
    Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
    Blomberg BA; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small animal positron emission tomography imaging and in vivo studies of atherosclerosis.
    Hag AM; Ripa RS; Pedersen SF; Bodholdt RP; Kjaer A
    Clin Physiol Funct Imaging; 2013 May; 33(3):173-85. PubMed ID: 23522010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
    Rudd JH; Myers KS; Bansilal S; Machac J; Rafique A; Farkouh M; Fuster V; Fayad ZA
    J Am Coll Cardiol; 2007 Aug; 50(9):892-6. PubMed ID: 17719477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
    Cocker MS; Mc Ardle B; Spence JD; Lum C; Hammond RR; Ongaro DC; McDonald MA; Dekemp RA; Tardif JC; Beanlands RS
    J Nucl Cardiol; 2012 Dec; 19(6):1211-25. PubMed ID: 23073913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
    Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
    Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
    Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
    Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.